Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. Founded in 1989 in Cambridge, Mass. and headquartered in Boston’s Innovation District, Vertex today has research and development sites and commercial offices in the United States, Europe, Canada and Australia. Read more about our global locations.
In addition to our clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and life-threatening diseases. Read more about our approved medicines and pipeline.
We collaborate with some of the world’s largest pharmaceutical companies, leading nonprofit disease foundations and many of the world’s best-known academic institutions. Read more about our collaborations.
Vertex has continually been recognized as one of the industry’s top workplaces by leading publications such as Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal.
